Meloxicam and Soliris drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Meloxicam (meloxicam) and Soliris (eculizumab). Common drug interactions include myalgia among females and vomiting among males.

The phase IV clinical study analyzes what interactions people have when they take Meloxicam and Soliris. It is created by eHealthMe based on reports of 29 people who take the same drugs from the FDA, and is updated regularly.

What is Meloxicam?

Meloxicam has active ingredients of meloxicam. It is often used in arthritis. eHealthMe is studying from 68,016 Meloxicam users. Check the latest studies of Meloxicam.

What is Soliris?

Soliris has active ingredients of eculizumab. It is often used in paroxysmal nocturnal hemoglobinuria (pnh). eHealthMe is studying from 58,821 Soliris users. Check the latest studies of Soliris.



On Jul, 12, 2026

29 people who take Meloxicam and Soliris together, and have interactions are studied.

Meloxicam and Soliris drug interactions.

What are the common drug interactions of Meloxicam and Soliris, by gender? *:

female:

  1. Myalgia (muscle pain)
  2. Nephrolithiasis (calculi in the kidneys)
  3. Osteoporosis (bones weak and more likely to break)
  4. Platelet count decreased
  5. Spinal cord injury
  6. Urinary tract infection
  7. Nausea (feeling of having an urge to vomit)
  8. Headache (pain in head)
  9. Anaemia (lack of blood)
  10. Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)

male:

  1. Vomiting
  2. Depression
  3. Diarrhoea
  4. Frustration (a form of poorly expressed anger)
  5. Haematocrit decreased
  6. Loss of consciousness
  7. Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
  8. Nausea (feeling of having an urge to vomit)
  9. Platelet count decreased
  10. Road traffic accident

What are the common drug interactions of Meloxicam and Soliris, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Depression
  2. Anxiety
  3. Diarrhoea
  4. Frustration (a form of poorly expressed anger)
  5. Loss of consciousness
  6. Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
  7. Nausea (feeling of having an urge to vomit)
  8. Road traffic accident
  9. Suicidal ideation
  10. Vomiting

30-39:

  1. Peripheral swelling
  2. Bone pain
  3. Infusion related reaction
  4. Erythema (redness of the skin)
  5. Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
  6. Rash
  7. Rash papular (redness with papule)
  8. Dyspnoea (difficult or laboured respiration)
  9. Muscular weakness (muscle weakness)
  10. Myalgia (muscle pain)

40-49:

n/a

50-59:

n/a

60+:

  1. Nausea (feeling of having an urge to vomit)
  2. Headache (pain in head)
  3. Fatigue (feeling of tiredness)
  4. Candidiasis (candidiasis or thrush is a fungal infection)
  5. Deafness
  6. Dyspnoea (difficult or laboured respiration)
  7. Ear infection bacterial
  8. Haemoglobinuria (the presence of free haemoglobin in the urine)
  9. Platelet count decreased
  10. Vertigo

What are the existing conditions these people have? *

  1. Myasthenia Gravis (a chronic condition that causes muscles to tire and weaken easily): 12 people, 41.38%
  2. Paroxysmal Nocturnal Haemoglobinuria (haemoglobin in the urine): 9 people, 31.03%
  3. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 5 people, 17.24%
  4. High Blood Pressure: 4 people, 13.79%
  5. Osteoporosis (bones weak and more likely to break): 4 people, 13.79%
  6. Connective Tissue Disorder (any disease that has the connective tissues of the body): 4 people, 13.79%
  7. Depression: 4 people, 13.79%
  8. Diabetes: 4 people, 13.79%
  9. Pain: 3 people, 10.34%
  10. Gout (uric acid crystals building up in the body): 3 people, 10.34%

* Approximation only. Some reports may have incomplete information.

Do you take Meloxicam and Soliris?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Meloxicam and Soliris:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Meloxicam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Soliris:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Meloxicam and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Soliris and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on meloxicam and eculizumab (the active ingredients of Meloxicam and Soliris, respectively), and Meloxicam and Soliris (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: